Microglial NLRP3 Inflammasome-mediated Neuroinflammation and Therapeutic Strategies in Depression

Overview

Journal Neural Regen Res

Date 2024 Jan 16

PMID 38227513

Authors

Qiuqin Han

Wenhui Li

Peiqing Chen

Lijuan Wang

Xiwen Bao

Renyan Huang

Guobin Liu

Xiaorong Chen

Affiliations

Soon will be listed here.

Abstract

Previous studies have demonstrated a bidirectional relationship between inflammation and depression. Activation of the nucleotide-binding oligomerization domain, leucine-rich repeat, and NLR family pyrin domain-containing 3 (NLRP3) inflammasomes is closely related to the pathogenesis of various neurological diseases. In patients with major depressive disorder, NLRP3 inflammasome levels are significantly elevated. Understanding the role that NLRP3 inflammasome-mediated neuroinflammation plays in the pathogenesis of depression may be beneficial for future therapeutic strategies. In this review, we aimed to elucidate the mechanisms that lead to the activation of the NLRP3 inflammasome in depression as well as to provide insight into therapeutic strategies that target the NLRP3 inflammasome. Moreover, we outlined various therapeutic strategies that target the NLRP3 inflammasome, including NLRP3 inflammatory pathway inhibitors, natural compounds, and other therapeutic compounds that have been shown to be effective in treating depression. Additionally, we summarized the application of NLRP3 inflammasome inhibitors in clinical trials related to depression. Currently, there is a scarcity of clinical trials dedicated to investigating the applications of NLRP3 inflammasome inhibitors in depression treatment. The modulation of NLRP3 inflammasomes in microglia holds promise for the management of depression. Further investigations are necessary to ascertain the efficacy and safety of these therapeutic approaches as potential novel antidepressant treatments.

Citing Articles

Fibromyalgia, Depression, and Autoimmune Disorders: An Interconnected Web of Inflammation.

Sedda S, Cadoni M, Medici S, Aiello E, Erre G, Nivoli A Biomedicines. 2025; 13(2).

PMID: 40002916 PMC: 11853372. DOI: 10.3390/biomedicines13020503.

Global trends of purinergic receptors and depression: A bibliometric analysis from 2003 to 2023.

Huang B, Chen W, Peng C, Shen X, Xue J, Yan C World J Psychiatry. 2025; 15(2):102344.

PMID: 39974485 PMC: 11758036. DOI: 10.5498/wjp.v15.i2.102344.

Is There such a Thing as Post-Viral Depression?: Implications for Precision Medicine.

Park E, Shin C, Jeon S, Ham B Biomol Ther (Seoul). 2024; 32(6):659-684.

PMID: 39428555 PMC: 11535299. DOI: 10.4062/biomolther.2024.170.

Peripheral mitochondrial DNA as a neuroinflammatory biomarker for major depressive disorder.

Ye J, Duan C, Han J, Chen J, Sun N, Li Y Neural Regen Res. 2024; 20(6):1541-1554.

PMID: 38934398 PMC: 11688552. DOI: 10.4103/NRR.NRR-D-23-01878.

Potassium and calcium channels in different nerve cells act as therapeutic targets in neurological disorders.

Qiu Q, Yang M, Gong D, Liang H, Chen T Neural Regen Res. 2024; 20(5):1258-1276.

PMID: 38845230 PMC: 11624876. DOI: 10.4103/NRR.NRR-D-23-01766.

References

Kajitani N, Iwata M, Miura A, Tsunetomi K, Yamanashi T, Matsuo R . Prefrontal cortex infusion of beta-hydroxybutyrate, an endogenous NLRP3 inflammasome inhibitor, produces antidepressant-like effects in a rodent model of depression. Neuropsychopharmacol Rep. 2020; 40(2):157-165. PMC: 7722664. DOI: 10.1002/npr2.12099. View

Li C, Zhu Y, Wu Y, Fu M, Wu Y, Wu Y . Oridonin Alleviates LPS-Induced Depression by Inhibiting NLRP3 Inflammasome Activation of Autophagy. Front Med (Lausanne). 2022; 8:813047. PMC: 8790066. DOI: 10.3389/fmed.2021.813047. View

Pan Y, Chen X, Zhang Q, Kong L . Microglial NLRP3 inflammasome activation mediates IL-1β-related inflammation in prefrontal cortex of depressive rats. Brain Behav Immun. 2014; 41:90-100. DOI: 10.1016/j.bbi.2014.04.007. View

Rakshasa-Loots A, Bakewell N, Sharp D, Gisslen M, Zetterberg H, Alagaratnam J . Biomarkers of central and peripheral inflammation mediate the association between HIV and depressive symptoms. Transl Psychiatry. 2023; 13(1):190. PMC: 10244452. DOI: 10.1038/s41398-023-02489-0. View

Zhang Y, Liu L, Liu Y, Shen X, Wu T, Zhang T . NLRP3 Inflammasome Mediates Chronic Mild Stress-Induced Depression in Mice via Neuroinflammation. Int J Neuropsychopharmacol. 2015; 18(8). PMC: 4571628. DOI: 10.1093/ijnp/pyv006. View

Zhang M, Wang X, Shi H, Meng L, Quan H, Yan L . Betaine Inhibits NLRP3 Inflammasome Hyperactivation and Regulates Microglial M1/M2 Phenotypic Differentiation, Thereby Attenuating Lipopolysaccharide-Induced Depression-Like Behavior. J Immunol Res. 2022; 2022:9313436. PMC: 9629937. DOI: 10.1155/2022/9313436. View

Lin Y, Wang S . Prenatal lipopolysaccharide exposure increases depression-like behaviors and reduces hippocampal neurogenesis in adult rats. Behav Brain Res. 2013; 259:24-34. DOI: 10.1016/j.bbr.2013.10.034. View

Harris A, Atsak P, Bretton Z, Holt E, Alam R, Morton M . A Novel Method for Chronic Social Defeat Stress in Female Mice. Neuropsychopharmacology. 2017; 43(6):1276-1283. PMC: 5916350. DOI: 10.1038/npp.2017.259. View

Wang Y, Liu Y, Zhang M, Zhou H, Gao Y, Cheng W . CY-09 Alleviates the Depression-like Behaviors via Inhibiting NLRP3 Inflammasome-Mediated Neuroinflammation in Lipopolysaccharide-Induced Mice. ACS Chem Neurosci. 2022; 13(23):3291-3302. DOI: 10.1021/acschemneuro.2c00348. View

10.

Liang T, Zhang Y, Wu S, Chen Q, Wang L . The Role of NLRP3 Inflammasome in Alzheimer's Disease and Potential Therapeutic Targets. Front Pharmacol. 2022; 13:845185. PMC: 8889079. DOI: 10.3389/fphar.2022.845185. View

11.

Menze E, Ezzat H, Shawky S, Sami M, Selim E, Ahmed S . Simvastatin mitigates depressive-like behavior in ovariectomized rats: Possible role of NLRP3 inflammasome and estrogen receptors' modulation. Int Immunopharmacol. 2021; 95:107582. DOI: 10.1016/j.intimp.2021.107582. View

12.

Song M, Ruan J, Zhang R, Deng J, Ma Z, Ma S . Astragaloside IV ameliorates neuroinflammation-induced depressive-like behaviors in mice via the PPARγ/NF-κB/NLRP3 inflammasome axis. Acta Pharmacol Sin. 2018; 39(10):1559-1570. PMC: 6289360. DOI: 10.1038/aps.2017.208. View

13.

Li H, Lin S, Qin T, Li H, Ma Z, Ma S . Senegenin exerts anti-depression effect in mice induced by chronic un-predictable mild stress via inhibition of NF-κB regulating NLRP3 signal pathway. Int Immunopharmacol. 2017; 53:24-32. DOI: 10.1016/j.intimp.2017.10.001. View

14.

Aghaie F, Moradifar F, Hosseini A . Rapamycin attenuates depression and anxiety-like behaviors through modulation of the NLRP3 pathway in pentylenetetrazole-kindled male Wistar rats. Fundam Clin Pharmacol. 2021; 35(6):1045-1054. DOI: 10.1111/fcp.12689. View

15.

Godbout J, Moreau M, Lestage J, Chen J, Sparkman N, OConnor J . Aging exacerbates depressive-like behavior in mice in response to activation of the peripheral innate immune system. Neuropsychopharmacology. 2007; 33(10):2341-51. PMC: 2907915. DOI: 10.1038/sj.npp.1301649. View

16.

Jiang N, Zhang Y, Yao C, Huang H, Wang Q, Huang S . Ginsenosides Rb1 Attenuates Chronic Social Defeat Stress-Induced Depressive Behavior Regulation of SIRT1-NLRP3/Nrf2 Pathways. Front Nutr. 2022; 9:868833. PMC: 9133844. DOI: 10.3389/fnut.2022.868833. View

17.

Haapakoski R, Mathieu J, Ebmeier K, Alenius H, Kivimaki M . Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder. Brain Behav Immun. 2015; 49:206-15. PMC: 4566946. DOI: 10.1016/j.bbi.2015.06.001. View

18.

Martinon F . Signaling by ROS drives inflammasome activation. Eur J Immunol. 2010; 40(3):616-9. DOI: 10.1002/eji.200940168. View

19.

Chai Y, Cai Y, Fu Y, Wang Y, Zhang Y, Zhang X . Salidroside Ameliorates Depression by Suppressing NLRP3-Mediated Pyroptosis P2X7/NF-κB/NLRP3 Signaling Pathway. Front Pharmacol. 2022; 13:812362. PMC: 9039222. DOI: 10.3389/fphar.2022.812362. View

20.

Wang Q, Bi H, Huang H, Wang Y, Gong L, Qi N . Electroacupuncture Prevents the Depression-Like Behavior by Inhibiting the NF-κB/NLRP3 Inflammatory Pathway in Hippocampus of Mice Subjected to Chronic Mild Stress. Neuropsychobiology. 2022; 81(3):237-245. DOI: 10.1159/000521185. View